Expert Opinion on Drug Discovery
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 7.3 | Q1 | 91.6% | 1.287 | Q1 | 89.5% |
| 2024 | 4.9 | Q1 | 86.7% | 1.195 | Q1 | 88.3% |
| 2023 | 6.0 | Q1 | 92.6% | 1.077 | Q1 | 87.3% |
| 2022 | 6.3 | Q1 | 90.7% | 1.219 | Q1 | 90.2% |
| 2021 | 7.0 | Q1 | 92.0% | 1.023 | Q1 | 87.0% |
| 2020 | — | — | 1.316 | Q1 | 90.5% | |
| 2019 | — | — | 1.160 | Q1 | 88.6% | |
| 2018 | — | — | 1.450 | Q1 | 91.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1746-0441
ISSN
1746-045X
country
GBcoverage
2006-2026